Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis A vaccine (live, attenuated) (Changchun Institute of Biological Products Co., Ltd.)
- Development stage
- Unknown
- Lead developer
- Changchun Institute of Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
A live attenuated vaccine developed by the Changchun Institute of Biological Products for the prevention of hepatitis A virus (HAV) infection. It is produced using the LA-1 strain of HAV, which is propagated in 2BS human embryonic lung diploid cells. The vaccine is provided in a freeze-dried (lyophilized) format to ensure greater thermal stability compared to liquid formulations, making it suitable for use in diverse environmental conditions. It is administered as a single subcutaneous dose and has been a core component of the Chinese National Immunization Program since 2007, primarily targeting toddlers and children.
- Other names
- hepatitis A live vaccine, freeze-dried (Changchun)Hepatitis A Vaccine, Live, Attenuated (Freeze-dried)LA-1 strain hepatitis A vaccineLA1 strain hepatitis A vaccineLA 1 strain hepatitis A vaccineChangchun Institute of Biological Products hepatitis A vaccine
Beyond the preview
Go deeper on hepatitis A vaccine (live, attenuated) (Changchun Institute of Biological Products Co., Ltd.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis A vaccine (live, attenuated) (Changchun Institute of Biological Products Co., Ltd.).